Oxford Genome Sciences (OGeS) is focused on developing new personalised medicines for the treatment of cancer based on capitalising on its Oxford Genome Anatomy Project (OGAP), the world's largest proprietary protein database with relevance to clinical medicine. OGAP is a unique integrated platform that combines genomic, proteomic and clinical information to discovery and validate of drug targets and biomarkers in man. We are in the process of expanding our team and are looking for individuals with the experience and enthusiasm to leverage our existing strategic alliances with Medarex and Biosite and to advance the company's growing oncology antibody portfolio.




News Feed